BusinessARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate UpdateBy Nasdaq OMXMay 8, 2018, 8:15 PM UTC
BusinessARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration AgreementBy Nasdaq OMXApr 23, 2018, 12:31 PM UTC
BusinessARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical TrialBy Nasdaq OMXFeb 26, 2018, 1:00 PM UTC
BusinessARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical TrialBy Nasdaq OMXJan 8, 2018, 1:31 PM UTC
BusinessARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic TargetingBy Nasdaq OMXNov 16, 2017, 1:30 PM UTC
